Renal failure is associated with the retention of a uraemia are yet to be fully elucidated. It has recently variety of toxic compounds responsible for the uraemic been demonstrated that renal failure is associated with syndrome. Initially, most of the symptoms of acute a dramatic elevation of advanced glycation end prod-uraemia were attributed to high blood urea levels and ucts (AGEs). These products are the result of the non-to acid-base and electrolyte disorders. Subsequently, enzymatic Maillard reaction linking a protein amino when it became clear that urea was not very toxic, a group with a glucose-derived aldehyde group. A mild variety of other protein-derived catabolic products rise of AGEs is associated with normal ageing. Proteins were incriminated. Among them, only a small minority with a slow turnover such as matrix proteins are thus has been convincingly associated with certain sympmodified and removed by an AGE-specific receptor-toms of acute renal failure. The development of renal mediated process thought to be a part of normal tissue replacement therapy, and especially dialysis, has led to remodelling. A more striking rise of AGEs is observed identification of a series of complications associated in diabetic patients as a result of sustained hyper-with long-term chronic renal failure (indeed the clearglycaemia. A greater variety of proteins is thus modi-ance capacity of three weekly dialysis is equivalent to fied leading to tissue damage through alteration of a creatinine clearance of approximately 10 ml/min). tissue protein structure and function, stimulation of These complications include a depressed immune several cellular responses, or generation of reactive response to infection, cardiovascular disorders includoxygen species. In uraemia, the rise of AGEs is even ing a specific uraemic cardiomyopathy, and dialysismore marked than in diabetics and is associated with related amyloidosis. Their specific causes are currently a variety of tissue disorders including vascular damage, being investigated. A number of compounds have been dyslipidaemia, and b 2 -microglobulin amyloidosis. incriminated, e.g. parathyroid hormone, b 2 -micro-AGE accumulation in uraemia does not result from globulin ( b 2 m), and p-cresol. In many instances, howhyperglycaemia. Identification of its cause as well as ever, the causal role of these 'toxins' remains debated. of the involved precursors should contribute to the The discovery that, in humans, long-lived proteins understanding of uraemic toxicity and open new thera-undergo progressive rearrangements has opened new peutic approaches. In this presentation, we propose avenues. These products, called advanced glycation the hypothesis that AGE generation is enhanced by an end products (AGEs), result from the Maillard reacincreased oxidative stress associated with uraemia. tion which, over a period of several months, links Under these conditions, a variety of compounds, both proteins with glucose-derived aldehydes resulting in related and unrelated to glucose, may contribute to Schiff bases, which are subsequently transformed the advanced glycoxidation of proteins. In uraemia, through molecular rearrangements into Amadori prodAGEs could be taken as a marker of oxidative stress ucts and eventually into irreversible AGEs [1]. This damage to proteins.
In 1988, the group of Vlassara demonstrated a marked increase of AGEs in the tissues of diabetic patients [1 ] . This increase was ascribed to hyperglycaemia: indeed a correlation was found between the levels of fructoselysine, a direct result of hyperglycaemia, and AGE levels both in the serum and in a variety of tissues [4 ] . Of great interest was the further demonstration of a relationship between serum and tissue AGE levels and the severity of diabetic complications [5, 6 ] . It was thus hypothesized that AGE modification of proteins played a causal role in the development of diabetic complications. Preliminary results of studies utilizing aminoguanidine, an inhibitor of advanced glycation, to prevent diabetic complications seem to support this hypothesis [7] .
The subsequent discovery that AGEs accumulate also in uraemic patients came as a great surprise. Observed serum AGE levels were indeed elevated more than 10-fold above those of diabetic patients and appeared unrelated to elevated glucose levels [8, 9] . This latter point was verified by the fact that, in contrast with diabetes, there is no correlation between serum levels of fructoselysine (mirroring elevated glucose levels) and AGEs [9 ] .
Two questions then arose: what is the relevance of elevated AGE levels in uraemia, and which are the determinants of AGE accumulation in uraemic patients? The relevance of AGE accumulation in bodies specifically stained amyloid deposits in dialysis by a crosslink between lysine and arginine residues resulting from patients [10, 12] . It was further demonstrated that the glycoxidation of Amadori products or a reaction of arabinose, AGE-b 2 m was capable of attracting monocytes [13 ] another autoxidative product of glucose. and of stimulating monocyte-derived macrophages exhibiting AGE receptors to release a variety of cytokines [13] [14] [15] [16] . Furthermore AGE-b 2 m stimulated Furthermore, as already stated, undetected fluctuations of blood glucose concentration cannot be invoked in osteoclast-induced bone resorption [17 ] . Preliminary evidence also suggests that AGEs play a critical role the absence of any correlation between pentosidine and fructoselysine levels. Obviously, uraemic sera conin the development of intimal hyperplasia in the vessels of uraemic subjects [our unpublished observation] .
tain either unknown precursors and/or catalysts of the Maillard reaction. Elucidation of the factors responsible for AGE formation proved more difficult. Indeed AGEs are
Recently gathered evidence has led us to postulate that an increased oxidative stress, characteristic of heterogeneous structures, some but not all of which have been identified. It thus became necessary to chronic uraemia, stimulates the oxidation of a variety of precursor substances which are unable, under identify with greater precision the structures of AGEs accumulating in renal failure. Two such structures have normal conditions, to augment AGE production. First, the formation of AGE products such as pentosidine been identified: pentosidine [18 ] and Ne-carboxymethyllysine (CML) [19 ] (Figure 1 ). Both are markedly and CML has been known for some years to be closely linked to 'oxidation' processes [21 ] . Figure 1 shows elevated in uraemic patients irrespective of the presence of diabetes [9, and our unpublished observation]. Both the Maillard reaction pathway leading to pentosidine and CML formation. CML was originally identified have been specifically identified in b 2 m amyloid deposits [12, 20] . Finally, both are present in the AGE as a product formed by oxidative cleavage of a glucosederived Amadori compound [19] . However, it was structures recognized in diabetic patients [4] .
The genesis of AGEs including pentosidine and recently demonstrated that glyoxal, which is formed on autoxidation of glucose, is also an efficient precursor CML in non-diabetic uraemic patients remains to be clarified. As pentosidine is mainly linked to albumin of CML [22] [23] [24] . Pentosidine was proposed to be formed spontaneously through a reaction of protein in the serum [9 ] , its accumulation cannot be attributed to a decreased removal by glomerular filtration. with ribose [18] , but arabinose, another autoxidative Enhanced glycoxidative stress in uraemia 257 product of glucose, is also a potential source of pentosidine [22, 23] . AGEs are thus products of the combined process of 'glycation' and 'oxidation'. This contention is supported by evidence that, in vitro, the absence of oxygen in the incubation medium prevents pentosidine and CML formation [19, 25] .
Second, it is of note that ascorbic acid is easily oxidized under oxidative stress and its oxidized form is an efficient precursor of both pentosidine and CML [25] [26] [27] . In vitro incubation of proteins with ascorbic acid under atmospheric oxygen, taken as oxidative stress, resulted in the rapid appearance of characteristic physicochemical properties of AGEs (brown colour, fluorescence, polymerization tendency) and the transformation into AGE-modified proteins recognized by Fig. 2 . Schematic representation of the hypothesis. In diabetic a specific monoclonal antibody [35 ] . These results patients with normal renal function, AGE levels increase because demonstrate that AGE production is accelerated under 'glycation' is enhanced due to sustained hyperglycaemia. By contrast oxidative stress even in the absence of glucose, sug-in uraemia, AGE levels increase in spite of normal glucose level because 'oxidation' is enhanced due to high oxidative stress.
gesting that, under oxidative stress, AGE production is also determined by the availability of precursors such as the oxidized form of ascorbic acid.
Third, chronic uraemia might be a state of increased antioxidant system within red blood cells. Pentosidine oxidative stress, as suggested by increased lipid peroxlevels are also correlated with products of monocyte idation assessed by malondialdehyde [28, 29] , an activation, a condition known to augment oxidative increased ratio of oxidized glutathione to reduced stress [34 ] . Thus, the hypothesis that an augmented glutathione [30, 31] , an increased ratio of oxidized form oxidative stress accelerates AGE formation in uraemia of albumin to reduced form of albumin [32] , and a opens new doors to the understanding of preferentially decreased activity of glutathione-dependent enzymes located AGE damage to various proteins in uraemic such as glutathione S-transferase, glutathione reductase patients. and glutathione peroxidase [31] . More recently,
In conclusion, several lines of evidence support the Witko-Sarsat et al.
[33] demonstrated elevated levels hypothesis that oxidation conspires with glycation to of 'advanced oxidation protein products (AOPP)' generate noxious advanced glycation end products in (taken as highly oxidized proteins) in sera of uraemic renal failure ( Figure 2 ). This hypothesis, if confirmed, patients.
might open the way to significant therapeutic We recently found that, in patients undergoing approaches and developments in the prevention of chronic haemodialysis, the ratio of oxidized form of complications associated with end-stage renal failure ascorbic acid to total ascorbate is increased. If this and chronic dialysis. ratio is taken as a marker of the redox state, this finding indicates a significantly higher oxidative stress in haemodialysis patients than in normal subjects.
Under these circumstances, there is a linear relationship References between the plasma levels of oxidized ascorbic acid and pentosidine [35] . This relationship is absent in
